Key Takeaways
- Capital reduction completed, promoter control cemented: 20% of share capital reduced, Rs.92 Cr paid out, and promoter stake crossed 51%, fulfilling a key commitment.
- Dehradun project is now a cash generator: The once-impaired residential project is debt-free, PBT positive, and expected to throw off ~Rs.100 Cr in cash including this year and the next year, with only 12 units left to sell.
- Care home occupancy is inflecting: Revenue grew 53% YoY in H1, occupancy ramped from 45% to 58% in Gurugram, and the flagship facility hit contribution breakeven within two years as guided.
- Noida project is a volume success but a margin cautionary tale: 313 of 340 units sold and price hikes absorbed a 50% material cost surge, yet the IRR will "definitely take a hit" versus the 20%+ aspiration, reinforcing the shift to an asset-light model.
- What to watch next quarter: Announcement of new Bengaluru or Gurugram projects, the pace of memory care bed fill, and whether the Greater Kailash care home reaches contribution breakeven in a few months' time.
Residential Real Estate: Cash Flow & Margin Reality
- Dehradun wind-down: Only 12 units remain unsold; monthly collections run at Rs.13 Cr and total collections reached Rs.592 Cr. The project is now debt-free, cash positive, and PBT positive.
- Dehradun cash return: Management estimates Rs.100 Cr in cash flow to the company over the next two years, plus Rs.12–15 Cr per year in steady-state operational income thereafter.
- Dehradun impairment legacy: A Rs.150 Cr impairment taken in FY20 absorbed cost-of-learning, capital gain tax issues, and delayed sales. Post-impairment, the balance sheet has stayed positive, and a surplus over the impairment is expected once all revenues are completed.
- Noida sales velocity: 313 of 340 units sold, with a record 20 units in October. Collections stand at Rs.166 Cr and construction is on track across three towers. A cumulative 50% price hike from inception helped absorb material cost inflation.
- Noida margin squeeze: Material costs rose at least 50% (e.g., steel from Rs.53,000 to Rs.75,000), and RERA rules prevent repricing already-sold units. The project was launched just before COVID, forcing Antara into land and construction roles it now avoids, compressing IRR below the 20%+ aspiration.
- Noida Phase 2 prep: Work has begun for a Phase 2 launch, driven by limited remaining inventory and a long waitlist.
Ajay Agrawal: "As far as return on investment is concerned because of the price increase of material cost, because of the uncertainties of land payments etc., while we aspire to be at 20% plus IRR we see that that will definitely take a hit."
Senior Care Services: Occupancy-Led Inflection
- Care home revenue growth: Revenue rose 53% YoY in H1FY23, with contribution margins improving from -32% to -29% as operating leverage builds.
- Gurugram occupancy ramp: Occupancy climbed from 45% to 58%, revenue grew 68% to Rs.1.7 Cr, and the facility achieved contribution breakeven within two years, exactly as previously guided. Long-stay residents drive the bulk of robust contribution margins.
- Greater Kailash breakeven expected soon: Management expects this facility to turn contribution positive in a few months.
- Care home unit economics: Break-even arrives at 45–50% occupancy and takes roughly eight quarters. Visit-to-conversion ratio runs at ~50%, with renewals at ~70%.
- Care at home margin swing: Contribution margin swung from 0.1% to 14% by focusing on high-end services: critical care, diagnostics, pathology, and physiotherapy. Steady-state margins are targeted at 15–20%.
- Medcare turnaround: Revenue up 36% and margin improved from -9% to 3%, driven by higher equipment rentals. Digital channel and white labelling are being explored to lift margins further.
- Category creation still the job: Management acknowledges the senior care market in NCR is becoming better known, with competitors now copying the model, but significant awareness-building work remains.
Rajit Mehta: "That is a great question, it is category creation job that we have to do actually."
Memory Care Launch & Bed Capacity Build-Out
- Memory care facility live: A 36-bed dedicated memory care home launched September 10th with dementia-trained staff, certified modules, and clinical protocols. Early traction: ~30 leads, three conversions in one month, and excellent feedback from patients and families.
- Bed capacity expansion: 63 beds added in Q2 (36 memory care, 13 with Medanta in Gurugram, 14 in Dwarka near Manipal). Total operational beds now exceed 150, with 75 more in the pipeline for ~225 beds by FY23 end.
- Memory care ambition: Management intends to open 10–15 memory care facilities across geographies over time.
- Long-term care home target: ~2,100 beds of care home and memory care home across North, West, and South.
Geographic & Asset-Light Expansion
- New city pipeline advancing: Projects in Gurugram and Bengaluru are in "very advanced stages," with aggressive scouting in the West cluster.
- Bengaluru residential model: First project targets 400–500 senior-living units. The model is explicitly asset-light: a partner brings land and construction, Antara takes a small equity stake to show skin in the game, and Antara solely handles design, sales, and operations.
- Bengaluru care homes: 200–260 beds planned across care homes, transition care, and memory care in the next two years.
- Future boundary conditions hardened: All future growth must clear an IRR hurdle of 20%+ and be asset-light, with no participation in land or construction. The Noida experience, where Antara "had to wear lot of new shoes" to protect brand value, is explicitly not the model going forward.
- DM Fee trajectory: The Noida project has started generating DM Fee income, which is steadily increasing. Management estimates four to five such projects are needed to fully absorb corporate costs.
- Capital adequacy: ~Rs.450 Cr in treasury and monetizable assets is available to fund growth.
Ajay Agarwal: "This is not the aspiration of Antara and as we explained in our various calls our boundary conditions for our future growth is to have an IRR of more than 20% and we need to be asset light, we don't want to participate in land, we don't want to participate in construction."
Revenue Target & Segment Mix
- Rs.500 Cr turnover target clarified: The five-year Rs.500 Cr target covers services only (care homes, care at home, medical equipment) and explicitly excludes residential-for-seniors revenue. Management did not update the timeline or confidence level when asked, with one year already elapsed.
- Residential communities aspiration: 8–10 communities targeted over the next five years.
- Medcare product launch: Four SKUs of an Antara-branded wheelchair, designed with senior-specific features, listed on Amazon in October 2022 with initial sales recorded.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Dehradun cash flow | Rs.100 Cr to the company | Over the next two years (current year + next) |
| Dehradun steady-state income | Rs.12–15 Cr per year operational income | Steady-state, post-completion |
| Noida possession | Hand over possession to buyers | Early 2025 |
| Care home bed capacity | 225 beds (150+ operational + 75 pipeline) | By FY23 end |
| Greater Kailash care home | Contribution positive | In a few months |
| Residential communities | 8–10 communities | Over the next five years |
| Care home / memory care beds | ~2,100 beds across North, West, South | No date (long-term target) |
| Bengaluru care homes | 200–260 beds | Over the next two years |
| Future project IRR floor | IRR of more than 20%, asset-light | All future growth |
| Care at home steady-state margin | 15–20% contribution margin | Steady-state |
Key Metrics
| Metric | Q2 FY23 |
|---|---|
| Consolidated revenue | ₹61 cr, +39% YoY |
| Consolidated revenue (H1 FY23) | ₹107 cr, +5% YoY |
| Consolidated EBITDA (H1 FY23) | 4.3x vs H1 FY22; +6% QoQ |
| Treasury corpus | ₹294 cr (monetizable assets ~₹450 cr) |
| Capital reduction completed | 20% of share capital reduced; ₹92 cr paid to shareholders |
| Promoter shareholding | 51.1%, up from 40.89% |
| Dehradun residential – units sold | 185 units sold; 12 units left in inventory |
| Dehradun residential – collections | ₹592 cr cumulative, +32% |
| Dehradun residential – monthly sales collection | ₹13 cr per month in Q2 FY23 |
| Noida residential – units sold | 313 of 340 units sold as of H1 FY23 |
| Noida residential – collections | ₹166 cr cumulative; 3.3x growth over quarter |
| Noida residential – monthly sales velocity | 12 units per month; October record 20 units |
| Noida residential – price hike from inception | ~50% to mitigate rising material costs |
| Noida residential – DM fee earned (H1 FY23) | >₹7 cr (on ~₹80 cr collections) |
| Care homes – revenue growth (H1 FY23) | +53% YoY |
| Care homes – contribution margin | -29%, improved from -32% |
| Care homes – net revenue growth | +40% YoY |
| Care homes – Gurugram occupancy | 58%, up from 45% |
| Care homes – Gurugram revenue (H1 FY23) | ₹1.7 cr, +68% |
| Care at home – net revenue | ₹1.6 cr, +37% QoQ |
| Care at home – contribution margin | 14%, up from 0.1% |
| Medcare – revenue | ₹0.7 cr, +36% |
| Medcare – margin | 3%, improved from -9% |
| Memory care home – launched | 36 beds added in Q2 FY23; ~10% occupancy in first month |
| Total care home beds (operational + pipeline) | 225 beds expected by FY23 end |
| Dehradun – estimated cash flow to company | ₹100 cr over next two years |
| Dehradun – steady-state operations revenue | ₹12–15 cr per year |
| Noida JV – Antara capital investment | ₹28 cr |
| Noida JV – Antara surplus share | 62.5% |
| Noida JV – ICD given | ₹25 cr at 9% interest |
| Noida JV – bridge funding planned | ~₹66 cr at 12–12.5% |
| Noida JV – estimated total sale value | <₹1,000–1,100 cr |
| Bengaluru residential – planned units | 400–500 units in first project |
| Bengaluru care homes – planned beds | 200–260 beds over two years |
| Care home break-even | 45–50% occupancy; ~8 quarters |
| Gurugram care home – break-even | 7 quarters; contribution positive for last 3 quarters |
| Capex – full-fledged care home / memory care home | ~₹1.5 cr |
| Capex – transition care (per room) | ~₹1 lakh |
| Resident satisfaction score | >91% |
| Sales from resident referrals | >50% |
| Antara Assisted Care satisfaction score | >92% |
| Antara Assisted Care renewal rate | ~70% |
| Care home visit-to-conversion ratio | ~50% |
| Patients served since inception | ~10,000 |
| Medcare – SKUs | 1,100+ |
| Medcare – products listed on Amazon | 4 wheelchair SKUs |